BioSpace - Financial Content

US-EUR-JAP BASKET PRINCIPAL PROTECTED CERTIFICATES Add to My Watchlist

(NYSE: AKN)

Detailed Quote

Last Price	8.15 (11.20.09 6:40 PM EST)
Change (%)	-0.30 (-3.58%)
Volume	200
Open	8.16
Previous Close	8.45
Day High	8.16
Day Low	8.15
Bid	N/A
Ask	N/A

Average Volume	2,899
Shares Outstanding	-
Market Cap	-
Year High	9.10
Year Low	6.90
Earnings Per Share	N/A
P/E Ratio	N/A
Dividend	N/A
Yield	N/A

Intraday

3 Month

6 Month

1 Year

Symbol	Last	Change (%)

Thu, Jan 25, 2007
	Akorn, Inc. Announces Move to Nasdaq Global Market - Business Wire
Tue, Jan 23, 2007
	Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R) - Business Wire
Tue, Jan 09, 2007
	Akorn, Inc. Signs Exclusive Definitive Agreement For the Development and Supply of Three Ophthalmic ANDA Drug Products - Business Wire
Wed, Dec 06, 2006
	Akorn, Inc. and Strides Arcolab Limited Agree to Expand the Akorn-Strides, LLC Joint Venture Product Pipeline to Twenty-Nine ANDA's - Business Wire
Thu, Nov 30, 2006
	Akorn, Inc. Announces Tentative Approval of Diclofenac Sodium Ophthalmic Solution 0.1% - Business Wire
More Press Releases

10/30/06		Q3 2006 Earnings Archive for AKN
07/31/06		Q2 2006 Earnings Archive for AKN
05/01/06		Q1 2006 Earnings Archive for AKN
03/06/06		Q4 2005 Earnings Archive for AKN

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs